$22 million gift from Alfred Taubman launches new biomedical research institute

September 26, 2007

ANN ARBOR, Mich. -- A new and extraordinary $22 million gift to the University of Michigan Health System is making possible a new and extraordinary institute -- one with a mission of supporting fundamental research to advance the understanding of the causes, treatment and prevention of a broad range of human diseases.

The A. Alfred Taubman Medical Research Institute, being established in the U-M Medical School, is named for the retail pioneer whose funding and vision led to its creation. Mr. Taubman's gift creates an endowment whose earnings will fund the institute, and the research of individual Taubman Scholars within the institute, for generations to come.

The first five Taubman Scholars have already been chosen from among the Medical School's top scientists. Each was selected for his or her remarkable creativity and research that holds the potential to significantly advance the development of a cure or preventive treatment for a human disease.

Each scientist will receive a three-year grant that will provide $200,000 per year for his or her laboratory team to use in their pursuit of new knowledge. This leaves them free to pursue the most promising possibilities. The scholars will also serve as advocates for research, by taking part in U-M efforts to educate the public about the importance of biomedical research, and of public and private support for such research.

At the end of three years, the scholars' grants may be renewed, and new scholars may be chosen from among the Medical School faculty, by an oversight committee chaired by U-M executive vice president for medical affairs Robert Kelch, M.D.

"We are on the doorstep of amazing scientific discoveries that will dramatically improve the health of people around the world," says Mr. Taubman, who attended the University of Michigan and has been one of the institution's most generous supporters, with lifetime giving of more than $60 million. "I am delighted to be able to support the important research of the university's talented scientists and physicians. I am especially proud that their groundbreaking work is being done right here in Michigan."

The new gift is a bold expression of faith in the potential impact of laboratory research, and in the strength of U-M's position in the life sciences, says Dr. Kelch. "Mr. Taubman clearly sees the value of giving brilliant people the freedom they need to explore new avenues, and to pursue innovative ideas, in the quest to overcome major diseases or reduce the impact of disease on individuals and society," he explains. "We are grateful for his generosity and his vision."

"Philanthropy is the lifeblood of the world's great universities," says University President Mary Sue Coleman. "Generous gifts such as Mr. Taubman's, which provide funds devoted specifically to seeding innovative research in perpetuity, are what ensure U-M's long-term ability to build and sustain its contributions to society. Moreover, in the process of conducting this research, we will also be able to train new generations of researchers and educators."

The timing of the new gift could not be better, says U-M Medical School Dean James O. Woolliscroft, M.D. "During a time when the federal government's financial support for research is wavering, philanthropic contributions are increasingly providing the support necessary to carry out promising research. At the same time, this gift allows us to recognize and support our distinguished investigators in a way that will surely help retain them at Michigan and attract future faculty as well."

The first five scholars are:The grants to these first five may be renewed at the end of three years depending on their research productivity. Additional scholars may be chosen in future as the endowment grows. Each scholar's proposal, whether new or renewing, will be evaluated in detail by the oversight committee, which will also hear a presentation from each prospective Taubman Scholar and visit his or her laboratory.

In addition to Dr. Kelch, the committee includes Dr. Woolliscroft; Kim Eagle, M.D., a director of the U-M Cardiovascular Center; Dr. Feldman, who was the first Taubman Scholar chosen; Mr. Taubman; and Jeffrey Miro, a Michigan-based attorney and adjunct professor at the U-M Law School. As the Institute goes forward, U-M will continue to have at least four representatives on the committee, with the Executive Vice President for Medical Affairs as chair or co-chair.
-end-
The U-M Health System is the academic medical center of the University of Michigan, and is considered one of the nation's leading medical care and research institutions. It comprises the U-M Medical School, its Faculty Group Practice and numerous research laboratories; three U-M-owned hospitals (University, C.S. Mott Children's, and Women's) with 913 licensed beds and nearly 48,500 admissions and births annually; more than 30 U-M health centers and 120 outpatient clinics where nearly 1.6 million patient visits take place each year; and nationally known centers for research, education and care in cancer, cardiovascular disease, depression, diabetes, geriatrics, organ transplant, vision and women's health. For more information, visit www.med.umich.edu.

University of Michigan Health System

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.